Press Release February 23, 2010
Eurofins AvTech Laboratories Adds Michael D. Barron to Team

(February 23, 2010; Portage, MI) – Eurofins AvTech Laboratories, a leading analytical contract research organization (CRO), is pleased to announce the addition of Michael D. Barron, MBA, to Eurofins AvTech.

Barron has been appointed director of business development at Eurofins AvTech. He will be responsible for developing contacts and building relationships with prospective and current clients – and for implementing strategies that will generate revenue growth.

Graduating from The Evergreen State College, located in Olympia, Washington, Barron earned a Bachelor of Science in life sciences. He also received a Master of Business Administration (MBA) from the University of North Carolina at Wilmington.

Barron’s previous positions have contributed to the structure of his significant industry experience, including those held at Catalent Pharma Solutions, Cardinal Health, and other leading contract drug development and analytical service companies. Additionally, Barron has been invited to speak at many industry conferences including American Association of Pharmaceutical Scientists (AAPS), Center for Business Intelligence (CBI), and IBC Life Sciences. He has also been selected to speak at internal strategic planning and educational events for large pharmaceutical companies.

“Michael is an experienced business development professional; we are excited he is part of the Eurofins AvTech team,” stated Eurofins AvTech President, Ray Farmen. “He has a strong network of contacts in the biopharmaceutical industry and a thorough understanding of the drug development process. Michael’s addition marks commitment to our clients and demonstrates our ability to attract high caliber individuals.”

About Eurofins AvTech Laboratories
Eurofins AvTech is an analytical contract research organization (CRO) serving the pharmaceutical industry since 1990. AvTech offers comprehensive analytical support for all stages of drug discovery and development from early ADME studies of drug candidates to stability and release testing of the finished product. Eurofins AvTech places special emphasis on the development, validation, and routine performance of GMP and GLP compliant methods.

 
Press Release March 31, 2009

Drug Research and Development Experts form Michigan CMC Alliance

(March 31, 2009; Kalamazoo, MI) – Several Michigan companies have formed a strategic alliance centered around pharmaceutical chemistry, manufacturing and control development (CMC), aptly called the Michigan CMC Alliance. This alliance is comprised of contract service providers, each an expert in a distinct component in the drug development spectrum, from preclinical to clinical phases and regulatory submission/approval.

Member organizations each have a firm foundation of experience and expertise within the pharmaceutical industry along with a scientific infrastructure to deliver cost-effective, compliant results. The ability to leverage the intellectual capital resident within each organization is a distinct advantage to those in need of pharmaceutical CMC resources and expert strategies for comprehensive drug development.

The Michigan CMC Alliance brings together the forces of:

  • Ash Stevens, Inc.: GMP API development and manufacturing
  • BioSTAT Consultants: Statistical services: design and analysis
  • Eurofins AvTech Laboratories, Inc.: GMP and GLP analytical services
  • Global Clinical Connections, LLC:  Clinical supplies management
  • Pharmaceutical Development Consulting, LLC: Formulation Development & Project Management
  • PharmaMed Resources, LLC: Quality assurance
  • ProReg Resources, LLC: Regulatory consulting services
  • Velesco Pharmaceutical Services: Formulation, analytical development and GMP manufacturing

"There is an abundance of pharma industry knowledge within Michigan; niche experts in each phase or components necessary to propel a drug forward through the development process. It seemed a natrual fit to combine our forces in a strategic alliance," stated Bill Pfund, a Director at Eurofins AvTech Laboratories. "Each company shares a common mission and vision along with a dedication to delivering quality, on-time results with the highest degree of scientific integrity."

Additional information on the Michigan CMC Alliance can be found at www.micmcalliance.com or by contacting 269-267-7290.

About Michigan CMC Alliance: Michigan CMC Alliance's mission is to support the growth and success of life science companies everywhere by providing CMC resources and expert strategies to drug development, as well as, education on the complexitites of the CMC development process, our member companies partner with clients and each other to deliver compliant, effective solutions that drive projects to success, on-time and within budget.

About Eurofins AvTech Laboratories: Eurofins AvTech is an analytical contract research organization (CRO) serving the pharmaceutical industry since 1990. AvTech offers comprehensive analytical support for all stages of drug discovery and development from early ADME studies of drug candidates, to stability and release testing of the finished product.  Eurofins AvTech places special emphasis on the development, validation, and routine performance of GMP and GLP compliant methods. 
 
Press Release - December 2008

Eurofins AvTech Announces Director of Business Development 

(Portage, MI; December 2, 2008) – Eurofins AvTech Laboratories (AvTech), located in Portage, Michigan, is pleased to announce the Director of Business Development, Jeff Moran.  Jeff will lead the business development team and enhance client relations through communication, marketing and strategy development by partnering with clients to get their drug products to market faster.  


Jeff possesses a unique combination of experience, with over eight years of successful business development supporting both bioanalysis and Phase I, along with more than 5 years of operational experience. He maintains expertise in the areas of quality systems, high-throughput LC-MS/MS, laboratory efficiency, bioanalytical regulations and client service.  Jeff has addressed these topics at industry conferences including AAPS, APA, Land-o-Lakes, ISLAR and TIW.  He has gained valuable and practical industry experience while advancing through various positions from laboratory analyst to business development.  Jeff earned his Bachelor of Science in Biological Sciences from the University of Nebraska, where he was a Regent Scholar.  


“Jeff’s knowledge of the industry serves to enhance client relations and expand AvTech’s bioanalytical reach,” stated Ray Farmen, president of Eurofins AvTech.  “With the outstanding experience that Jeff has gained over the years, he will do an excellent job with our business development team.”
“I am excited to take this leadership position and develop a strategy to enhance our business development team,” stated Jeff Moran.  “I am confident that with my experience in the pharmaceutical industry I can be a key part of the team that will successfully build Eurofins AvTech.”


About Eurofins AvTech Laboratories
Eurofins AvTech is an analytical contract research organization (CRO) serving the pharmaceutical industry since 1990. AvTech offers comprehensive analytical support for all stages of drug discovery and development from early ADME studies of drug candidates, to stability and release testing of the finished product.  Eurofins AvTech places special emphasis on the development, validation, and routine performance of GMP and GLP compliant methods. 
 
Press Release - September 2008

Eurofins AvTech Laboratories Strengthens Management Team  

(Portage, MI; September 9, 2008) – Eurofins AvTech Laboratories (AvTech), located in Portage, Michigan, is pleased to announce the addition of three exceptional individuals to bolster its senior management team. 

Raymond Farmen, Ph.D., has been appointed President of Eurofins AvTech Laboratories. Farmen graduated with a Ph.D. from the Indiana University School of Medicine and has built significant pharmaceutical industry experience from positions held at Bristol-Myers Squibb and various analytical service and consulting companies. Of particular note are the many leadership positions Farmen held at Camargo Pharmaceutical Services, MDS Pharma Services, and Phoenix International Life Sciences.  As President at AvTech, Farmen provides technical and scientific direction for method development, bioanalytical, product testing, and animal health areas.  In addition, he is responsible for general management, technical, and profit/loss decisions for the company. 

Steven Weber, Ph.D., joined AvTech’s senior management team as Director, Bioanalytical. Weber’s experience includes work at Pfizer, as a Senior Director in Pharmacokinetics, Dynamics, and Metabolism-Michigan (PDM-MI).  While in this role, his responsibilities included oversight of all PDM-MI regulated bioanalytical and toxicokinetic support, the Mass Balance/ADME center of excellence, and the PDM-Resource Lab.

Leon Clark, Jr. also joined the senior management team as Director, Animal Health.  Prior to joining AvTech, Clark managed more than 200 employees at Pfizer and developed, tested, and implemented the Rapid Laboratory concept.  His management experience and analytical expertise will be a great asset to AvTech. 

“We are very excited to welcome Ray, Steve, and Leon to our senior management team – they have outstanding academic backgrounds and industry experience,” stated Luc Leroy, CEO of Eurofins Pharma Services.  “I am confident that their significant scientific and operational talents will allow AvTech to accelerate its growth while maintaining the ability to provide our clients with exceptional service and regulatory compliance.”

About Eurofins AvTech Laboratories <http://www.avtechlabs.com/> 
Eurofins AvTech is an analytical contract research organization (CRO) serving the pharmaceutical industry since 1990. AvTech offers comprehensive analytical support for all stages of drug discovery and development from early ADME studies of drug candidates, to stability and release testing of the finished product.  Eurofins AvTech places special emphasis on the development, validation, and routine performance of GMP and GLP compliant methods.
 
2009 Conference Schedule

Eurofins AvTech Laboratories staff will be attending numerous conferences and workshops in 2009. Some of the events that we will be attending are listed below.  We invite you to visit us at the booth locations indicated, or contact us in advance to schedule an individual meeting with one of our scientists.  Please note that the list of events that we will be attending will be updated as new events are added to our schedule.  We therefore encourage you to check this page periodically to see recent additions to the list.

BIO 2009 (Booth #5211)
May 18-21, 2009
Georgia World Congress Center, Atlanta, GA

Interphex 2009 (Booth #574)
March 17-19, 2009
Jacob K. Javits Convention Center, New York, New York

16th North American Regional Meeting of the ISSX (Booth #405)
October 18-22, 2009
Marriott Waterfront Hotel, Baltimore, Maryland

2009 AAPS Annual Meeting and Exposition (Booth #509)
November 9-12, 2009
Los Angeles Convention Center, Los Angeles, California